1 | varying | 2,968 |
2 | differing | 1,259 |
3 | contrasting | 408 |
4 | graduated | 227 |
5 | propagating | 72 |
6 | diverging | 51 |
7 | deviating | 40 |
8 | single-digit | 16 |
9 | low-to-high | 11 |
10 | overoptimistic | 10 |
11 | 20× | 9 |
12 | medium-to-high | 9 |
13 | unexplainable | 9 |
14 | irreconcilable | 7 |
15 | middle-high | 6 |
16 | nonbelieved | 6 |
17 | c-24 | 5 |
18 | equihypotensive | 5 |
19 | unabsorbed | 5 |
20 | degrees+/-0.2 | 4 |
21 | non-addictive | 4 |
22 | sub-stoichiometric | 4 |
23 | 100-microm | 3 |
24 | 45-45.5 | 3 |
25 | before-treatment | 3 |
26 | degrees-44 | 3 |
27 | microbiopsies | 3 |
28 | non-simultaneous | 3 |
29 | rs6013897 | 3 |
30 | rw-37 | 3 |
31 | subfemtomole | 3 |
32 | 200-360 | 2 |
33 | 22.0+/-0.5 | 2 |
34 | 26.33+/-1.29 | 2 |
35 | 35.33+/-0.35 | 2 |
36 | 42-42.5 | 2 |
37 | 46.1-47 | 2 |
38 | 580-750 | 2 |
39 | =36.8 | 2 |
40 | adenosine-derived | 2 |
41 | beta=15 | 2 |
42 | bspharm | 2 |
43 | complete-data | 2 |
44 | degrees+/-0.3 | 2 |
45 | degrees-45 | 2 |
46 | device/drug | 2 |
47 | ferrofluid | 2 |
48 | flexible-monomer | 2 |
49 | ginlac-v. | 2 |
50 | ksha1 | 2 |
51 | libh4 | 2 |
52 | medium-potency | 2 |
53 | nonsynergistic | 2 |
54 | np-v | 2 |
55 | ppm/ | 2 |
56 | prolonged-qtc | 2 |
57 | sub-harmonic | 2 |
58 | very-low-activity | 2 |
59 | xenon-133 | 2 |
60 | βz | 2 |
61 | +/-0.025 | 1 |
62 | -0.9+/-0.3 | 1 |
63 | -1.0+/-0.3 | 1 |
64 | -1.3+/-0.1 | 1 |
65 | -1.3+/-0.3 | 1 |
66 | -1.6+/-0.2 | 1 |
67 | -17.7+/-3.4 | 1 |
68 | -22.0+/-1.7 | 1 |
69 | -8.2+/-2.0 | 1 |
70 | 0.10+/-0.94 | 1 |
71 | 0.2±1.8 | 1 |
72 | 0.5±5.1 | 1 |
73 | 0.7+/-0.1 | 1 |
74 | 1,400-1,550 | 1 |
75 | 1-40.2 | 1 |
76 | 1.24+/-1 | 1 |
77 | 1.33-2.88 | 1 |
78 | 1.34+/-0.19 | 1 |
79 | 1.7-100 | 1 |
80 | 1.9-10.5 | 1 |
81 | 1.9±4.9 | 1 |
82 | 13.5-17.5 | 1 |
83 | 131° | 1 |
84 | 16.5-18.8 | 1 |
85 | 17+/-1 | 1 |
86 | 190-280 | 1 |
87 | 20-lb | 1 |
88 | 20062007 | 1 |
89 | 201.72 | 1 |
90 | 22.2-24.4 | 1 |
91 | 24.6-25.0 | 1 |
92 | 25.2+/-1.56 | 1 |
93 | 250-370 | 1 |
94 | 26-/+0.5 | 1 |
95 | 26.5-28 | 1 |
96 | 29.4-30.8 | 1 |
97 | 290-310 | 1 |
98 | 3,649 | 1 |
99 | 30-400 | 1 |
100 | 300,523 | 1 |
101 | 30d/34 | 1 |
102 | 31.3-32.3 | 1 |
103 | 33,358 | 1 |
104 | 35.0+/-0.3 | 1 |
105 | 35.0-/+0.5 | 1 |
106 | 35.0-40.6 | 1 |
107 | 35.6-43.9 | 1 |
108 | 36+/-0.3 | 1 |
109 | 36/26 | 1 |
110 | 37.73-37.86 | 1 |
111 | 38.0-38.4 | 1 |
112 | 38.0-39.5 | 1 |
113 | 380-510 | 1 |
114 | 39.0+/-0.5 | 1 |
115 | 39.0-43.0 | 1 |
116 | 39.2+/-0.2 | 1 |
117 | 39.2-40.9 | 1 |
118 | 4.4-15 | 1 |
119 | 4.8-12.2 | 1 |
120 | 40+/-1 | 1 |
121 | 40.3+/-0.11 | 1 |
122 | 41-41.5 | 1 |
123 | 41.0-42.0 | 1 |
124 | 41.1-43.1 | 1 |
125 | 41.5-44 | 1 |
126 | 41.7+/-0.9 | 1 |
127 | 41.7-42 | 1 |
128 | 41.8+/-0.5 | 1 |
129 | 41.9-42.2 | 1 |
130 | 42-42.4 | 1 |
131 | 42.0-43.7 | 1 |
132 | 42.4±18.6 | 1 |
133 | 42.5-43.5 | 1 |
134 | 42/35 | 1 |
135 | 42/39 | 1 |
136 | 44-96 | 1 |
137 | 46.914 | 1 |
138 | 47-50 | 1 |
139 | 5.2±3.6 | 1 |
140 | 5.7-14.3 | 1 |
141 | 50-μg/d | 1 |
142 | 53-55 | 1 |
143 | 55.3±7 | 1 |
144 | 579-732 | 1 |
145 | 587-707 | 1 |
146 | 597-747 | 1 |
147 | 6.8+/-1.8 | 1 |
148 | 600-850 | 1 |
149 | 7,496.3 | 1 |
150 | 7-40.9 | 1 |
151 | 75-110 | 1 |
152 | 800-850 | 1 |
153 | 87-104 | 1 |
154 | =-0.4+/-0.2 | 1 |
155 | =35.5 | 1 |
156 | =36.5 | 1 |
157 | adimensional | 1 |
158 | agreement.main | 1 |
159 | andfinal | 1 |
160 | beta=30 | 1 |
161 | beta=5 | 1 |
162 | board-type | 1 |
163 | cd-monitored | 1 |
164 | cool-25 | 1 |
165 | ctare | 1 |
166 | d64 | 1 |
167 | db/33 | 1 |
168 | degrees-22 | 1 |
169 | degrees-30.7 | 1 |
170 | degrees-43 | 1 |
171 | degrees-60 | 1 |
172 | degrees/25 | 1 |
173 | dibenzo-alpha-pyrones | 1 |
174 | discussion.main | 1 |
175 | eosinophila | 1 |
176 | gc-ms/gc-fid | 1 |
177 | half-effective | 1 |
178 | hearable | 1 |
179 | helminth-egg | 1 |
180 | hi-33 | 1 |
181 | hi-35 | 1 |
182 | homoiothermical | 1 |
183 | hot-35 | 1 |
184 | hr43 | 1 |
185 | hsp6 | 1 |
186 | hydration-dehydration | 1 |
187 | increasing-on-admission | 1 |
188 | infant-series | 1 |
189 | infrasonic | 1 |
190 | inrplus-proposed | 1 |
191 | iron-saturation | 1 |
192 | isocoagulation | 1 |
193 | j./ | 1 |
194 | list-dynamic | 1 |
195 | low-chlorine | 1 |
196 | low-spatial | 1 |
197 | lower-radiation | 1 |
198 | medigap | 1 |
199 | mid-khz | 1 |
200 | multi-vibrational-mode | 1 |
201 | near-toxic | 1 |
202 | neitralisation | 1 |
203 | non-fistulizing | 1 |
204 | nonomolar | 1 |
205 | plausability | 1 |
206 | poh24 | 1 |
207 | pre-g-csf | 1 |
208 | propargate | 1 |
209 | propogating | 1 |
210 | resident-based | 1 |
211 | respectively.similar | 1 |
212 | semiologic | 1 |
213 | sham-33 | 1 |
214 | small-effect | 1 |
215 | standard/higher | 1 |
216 | sub-antinociceptive | 1 |
217 | sulfurous-arsenical-ferruginous | 1 |
218 | superlow | 1 |
219 | thromboxaneb2 | 1 |
220 | two-actuation | 1 |
221 | two-different | 1 |
222 | uranyl-cyt | 1 |
223 | varicella/zoster | 1 |
224 | w/m* | 1 |
225 | warm-35 | 1 |
226 | weight-equivalent | 1 |
227 | ~10-mg | 1 |
1 | +/-0.025 | 1 |
2 | -0.9+/-0.3 | 1 |
3 | -1.0+/-0.3 | 1 |
4 | -1.3+/-0.1 | 1 |
5 | -1.3+/-0.3 | 1 |
6 | -1.6+/-0.2 | 1 |
7 | -17.7+/-3.4 | 1 |
8 | -22.0+/-1.7 | 1 |
9 | -8.2+/-2.0 | 1 |
10 | 0.10+/-0.94 | 1 |
11 | 0.2±1.8 | 1 |
12 | 0.5±5.1 | 1 |
13 | 0.7+/-0.1 | 1 |
14 | 1,400-1,550 | 1 |
15 | 1-40.2 | 1 |
16 | 1.24+/-1 | 1 |
17 | 1.33-2.88 | 1 |
18 | 1.34+/-0.19 | 1 |
19 | 1.7-100 | 1 |
20 | 1.9-10.5 | 1 |
21 | 1.9±4.9 | 1 |
22 | 100-microm | 3 |
23 | 13.5-17.5 | 1 |
24 | 131° | 1 |
25 | 16.5-18.8 | 1 |
26 | 17+/-1 | 1 |
27 | 190-280 | 1 |
28 | 20-lb | 1 |
29 | 200-360 | 2 |
30 | 20062007 | 1 |
31 | 201.72 | 1 |
32 | 20× | 9 |
33 | 22.0+/-0.5 | 2 |
34 | 22.2-24.4 | 1 |
35 | 24.6-25.0 | 1 |
36 | 25.2+/-1.56 | 1 |
37 | 250-370 | 1 |
38 | 26-/+0.5 | 1 |
39 | 26.33+/-1.29 | 2 |
40 | 26.5-28 | 1 |
41 | 29.4-30.8 | 1 |
42 | 290-310 | 1 |
43 | 3,649 | 1 |
44 | 30-400 | 1 |
45 | 300,523 | 1 |
46 | 30d/34 | 1 |
47 | 31.3-32.3 | 1 |
48 | 33,358 | 1 |
49 | 35.0+/-0.3 | 1 |
50 | 35.0-/+0.5 | 1 |
51 | 35.0-40.6 | 1 |
52 | 35.33+/-0.35 | 2 |
53 | 35.6-43.9 | 1 |
54 | 36+/-0.3 | 1 |
55 | 36/26 | 1 |
56 | 37.73-37.86 | 1 |
57 | 38.0-38.4 | 1 |
58 | 38.0-39.5 | 1 |
59 | 380-510 | 1 |
60 | 39.0+/-0.5 | 1 |
61 | 39.0-43.0 | 1 |
62 | 39.2+/-0.2 | 1 |
63 | 39.2-40.9 | 1 |
64 | 4.4-15 | 1 |
65 | 4.8-12.2 | 1 |
66 | 40+/-1 | 1 |
67 | 40.3+/-0.11 | 1 |
68 | 41-41.5 | 1 |
69 | 41.0-42.0 | 1 |
70 | 41.1-43.1 | 1 |
71 | 41.5-44 | 1 |
72 | 41.7+/-0.9 | 1 |
73 | 41.7-42 | 1 |
74 | 41.8+/-0.5 | 1 |
75 | 41.9-42.2 | 1 |
76 | 42-42.4 | 1 |
77 | 42-42.5 | 2 |
78 | 42.0-43.7 | 1 |
79 | 42.4±18.6 | 1 |
80 | 42.5-43.5 | 1 |
81 | 42/35 | 1 |
82 | 42/39 | 1 |
83 | 44-96 | 1 |
84 | 45-45.5 | 3 |
85 | 46.1-47 | 2 |
86 | 46.914 | 1 |
87 | 47-50 | 1 |
88 | 5.2±3.6 | 1 |
89 | 5.7-14.3 | 1 |
90 | 50-μg/d | 1 |
91 | 53-55 | 1 |
92 | 55.3±7 | 1 |
93 | 579-732 | 1 |
94 | 580-750 | 2 |
95 | 587-707 | 1 |
96 | 597-747 | 1 |
97 | 6.8+/-1.8 | 1 |
98 | 600-850 | 1 |
99 | 7,496.3 | 1 |
100 | 7-40.9 | 1 |
101 | 75-110 | 1 |
102 | 800-850 | 1 |
103 | 87-104 | 1 |
104 | =-0.4+/-0.2 | 1 |
105 | =35.5 | 1 |
106 | =36.5 | 1 |
107 | =36.8 | 2 |
108 | adenosine-derived | 2 |
109 | adimensional | 1 |
110 | agreement.main | 1 |
111 | andfinal | 1 |
112 | before-treatment | 3 |
113 | beta=15 | 2 |
114 | beta=30 | 1 |
115 | beta=5 | 1 |
116 | board-type | 1 |
117 | bspharm | 2 |
118 | c-24 | 5 |
119 | cd-monitored | 1 |
120 | complete-data | 2 |
121 | contrasting | 408 |
122 | cool-25 | 1 |
123 | ctare | 1 |
124 | d64 | 1 |
125 | db/33 | 1 |
126 | degrees+/-0.2 | 4 |
127 | degrees+/-0.3 | 2 |
128 | degrees-22 | 1 |
129 | degrees-30.7 | 1 |
130 | degrees-43 | 1 |
131 | degrees-44 | 3 |
132 | degrees-45 | 2 |
133 | degrees-60 | 1 |
134 | degrees/25 | 1 |
135 | deviating | 40 |
136 | device/drug | 2 |
137 | dibenzo-alpha-pyrones | 1 |
138 | differing | 1,259 |
139 | discussion.main | 1 |
140 | diverging | 51 |
141 | eosinophila | 1 |
142 | equihypotensive | 5 |
143 | ferrofluid | 2 |
144 | flexible-monomer | 2 |
145 | gc-ms/gc-fid | 1 |
146 | ginlac-v. | 2 |
147 | graduated | 227 |
148 | half-effective | 1 |
149 | hearable | 1 |
150 | helminth-egg | 1 |
151 | hi-33 | 1 |
152 | hi-35 | 1 |
153 | homoiothermical | 1 |
154 | hot-35 | 1 |
155 | hr43 | 1 |
156 | hsp6 | 1 |
157 | hydration-dehydration | 1 |
158 | increasing-on-admission | 1 |
159 | infant-series | 1 |
160 | infrasonic | 1 |
161 | inrplus-proposed | 1 |
162 | iron-saturation | 1 |
163 | irreconcilable | 7 |
164 | isocoagulation | 1 |
165 | j./ | 1 |
166 | ksha1 | 2 |
167 | libh4 | 2 |
168 | list-dynamic | 1 |
169 | low-chlorine | 1 |
170 | low-spatial | 1 |
171 | low-to-high | 11 |
172 | lower-radiation | 1 |
173 | medigap | 1 |
174 | medium-potency | 2 |
175 | medium-to-high | 9 |
176 | microbiopsies | 3 |
177 | mid-khz | 1 |
178 | middle-high | 6 |
179 | multi-vibrational-mode | 1 |
180 | near-toxic | 1 |
181 | neitralisation | 1 |
182 | non-addictive | 4 |
183 | non-fistulizing | 1 |
184 | non-simultaneous | 3 |
185 | nonbelieved | 6 |
186 | nonomolar | 1 |
187 | nonsynergistic | 2 |
188 | np-v | 2 |
189 | overoptimistic | 10 |
190 | plausability | 1 |
191 | poh24 | 1 |
192 | ppm/ | 2 |
193 | pre-g-csf | 1 |
194 | prolonged-qtc | 2 |
195 | propagating | 72 |
196 | propargate | 1 |
197 | propogating | 1 |
198 | resident-based | 1 |
199 | respectively.similar | 1 |
200 | rs6013897 | 3 |
201 | rw-37 | 3 |
202 | semiologic | 1 |
203 | sham-33 | 1 |
204 | single-digit | 16 |
205 | small-effect | 1 |
206 | standard/higher | 1 |
207 | sub-antinociceptive | 1 |
208 | sub-harmonic | 2 |
209 | sub-stoichiometric | 4 |
210 | subfemtomole | 3 |
211 | sulfurous-arsenical-ferruginous | 1 |
212 | superlow | 1 |
213 | thromboxaneb2 | 1 |
214 | two-actuation | 1 |
215 | two-different | 1 |
216 | unabsorbed | 5 |
217 | unexplainable | 9 |
218 | uranyl-cyt | 1 |
219 | varicella/zoster | 1 |
220 | varying | 2,968 |
221 | very-low-activity | 2 |
222 | w/m* | 1 |
223 | warm-35 | 1 |
224 | weight-equivalent | 1 |
225 | xenon-133 | 2 |
226 | ~10-mg | 1 |
227 | βz | 2 |
1 | w/m* | 1 |
2 | ginlac-v. | 2 |
3 | j./ | 1 |
4 | ppm/ | 2 |
5 | -8.2+/-2.0 | 1 |
6 | 41.0-42.0 | 1 |
7 | 39.0-43.0 | 1 |
8 | 24.6-25.0 | 1 |
9 | 1.7-100 | 1 |
10 | 30-400 | 1 |
11 | 75-110 | 1 |
12 | 290-310 | 1 |
13 | 380-510 | 1 |
14 | beta=30 | 1 |
15 | 47-50 | 1 |
16 | 1,400-1,550 | 1 |
17 | 580-750 | 2 |
18 | 600-850 | 1 |
19 | 800-850 | 1 |
20 | degrees-60 | 1 |
21 | 200-360 | 2 |
22 | 250-370 | 1 |
23 | 190-280 | 1 |
24 | 40+/-1 | 1 |
25 | 1.24+/-1 | 1 |
26 | 17+/-1 | 1 |
27 | -1.3+/-0.1 | 1 |
28 | 0.7+/-0.1 | 1 |
29 | 41.1-43.1 | 1 |
30 | 0.5±5.1 | 1 |
31 | 40.3+/-0.11 | 1 |
32 | ksha1 | 2 |
33 | 39.2+/-0.2 | 1 |
34 | =-0.4+/-0.2 | 1 |
35 | -1.6+/-0.2 | 1 |
36 | degrees+/-0.2 | 4 |
37 | 1-40.2 | 1 |
38 | 4.8-12.2 | 1 |
39 | 41.9-42.2 | 1 |
40 | degrees-22 | 1 |
41 | 579-732 | 1 |
42 | 41.7-42 | 1 |
43 | 201.72 | 1 |
44 | thromboxaneb2 | 1 |
45 | -1.0+/-0.3 | 1 |
46 | 35.0+/-0.3 | 1 |
47 | -1.3+/-0.3 | 1 |
48 | 36+/-0.3 | 1 |
49 | -0.9+/-0.3 | 1 |
50 | degrees+/-0.3 | 2 |
51 | 31.3-32.3 | 1 |
52 | 5.7-14.3 | 1 |
53 | 7,496.3 | 1 |
54 | 300,523 | 1 |
55 | hi-33 | 1 |
56 | sham-33 | 1 |
57 | db/33 | 1 |
58 | xenon-133 | 2 |
59 | degrees-43 | 1 |
60 | hr43 | 1 |
61 | 42-42.4 | 1 |
62 | -17.7+/-3.4 | 1 |
63 | 22.2-24.4 | 1 |
64 | 38.0-38.4 | 1 |
65 | 87-104 | 1 |
66 | 46.914 | 1 |
67 | c-24 | 5 |
68 | poh24 | 1 |
69 | 30d/34 | 1 |
70 | 41.5-44 | 1 |
71 | degrees-44 | 3 |
72 | d64 | 1 |
73 | 0.10+/-0.94 | 1 |
74 | libh4 | 2 |
75 | 35.0-/+0.5 | 1 |
76 | 26-/+0.5 | 1 |
77 | 22.0+/-0.5 | 2 |
78 | 39.0+/-0.5 | 1 |
79 | 41.8+/-0.5 | 1 |
80 | 1.9-10.5 | 1 |
81 | 41-41.5 | 1 |
82 | 42-42.5 | 2 |
83 | 42.5-43.5 | 1 |
84 | =35.5 | 1 |
85 | 45-45.5 | 3 |
86 | =36.5 | 1 |
87 | 13.5-17.5 | 1 |
88 | 38.0-39.5 | 1 |
89 | 4.4-15 | 1 |
90 | beta=15 | 2 |
91 | cool-25 | 1 |
92 | degrees/25 | 1 |
93 | +/-0.025 | 1 |
94 | hi-35 | 1 |
95 | warm-35 | 1 |
96 | hot-35 | 1 |
97 | 35.33+/-0.35 | 2 |
98 | 42/35 | 1 |
99 | degrees-45 | 2 |
100 | 53-55 | 1 |
101 | beta=5 | 1 |
102 | 35.0-40.6 | 1 |
103 | 5.2±3.6 | 1 |
104 | 42.4±18.6 | 1 |
105 | 36/26 | 1 |
106 | 25.2+/-1.56 | 1 |
107 | 37.73-37.86 | 1 |
108 | 44-96 | 1 |
109 | hsp6 | 1 |
110 | degrees-30.7 | 1 |
111 | -22.0+/-1.7 | 1 |
112 | 42.0-43.7 | 1 |
113 | 20062007 | 1 |
114 | 587-707 | 1 |
115 | rw-37 | 3 |
116 | 46.1-47 | 2 |
117 | 597-747 | 1 |
118 | rs6013897 | 3 |
119 | 55.3±7 | 1 |
120 | 29.4-30.8 | 1 |
121 | 6.8+/-1.8 | 1 |
122 | 0.2±1.8 | 1 |
123 | =36.8 | 2 |
124 | 16.5-18.8 | 1 |
125 | 26.5-28 | 1 |
126 | 33,358 | 1 |
127 | 1.33-2.88 | 1 |
128 | 41.7+/-0.9 | 1 |
129 | 39.2-40.9 | 1 |
130 | 7-40.9 | 1 |
131 | 35.6-43.9 | 1 |
132 | 1.9±4.9 | 1 |
133 | 1.34+/-0.19 | 1 |
134 | 26.33+/-1.29 | 2 |
135 | 42/39 | 1 |
136 | 3,649 | 1 |
137 | eosinophila | 1 |
138 | complete-data | 2 |
139 | 20-lb | 1 |
140 | semiologic | 1 |
141 | list-dynamic | 1 |
142 | sub-harmonic | 2 |
143 | infrasonic | 1 |
144 | sub-stoichiometric | 4 |
145 | nonsynergistic | 2 |
146 | overoptimistic | 10 |
147 | near-toxic | 1 |
148 | prolonged-qtc | 2 |
149 | 50-μg/d | 1 |
150 | unabsorbed | 5 |
151 | cd-monitored | 1 |
152 | resident-based | 1 |
153 | inrplus-proposed | 1 |
154 | graduated | 227 |
155 | nonbelieved | 6 |
156 | adenosine-derived | 2 |
157 | gc-ms/gc-fid | 1 |
158 | ferrofluid | 2 |
159 | multi-vibrational-mode | 1 |
160 | irreconcilable | 7 |
161 | unexplainable | 9 |
162 | hearable | 1 |
163 | subfemtomole | 3 |
164 | low-chlorine | 1 |
165 | board-type | 1 |
166 | ctare | 1 |
167 | propargate | 1 |
168 | equihypotensive | 5 |
169 | half-effective | 1 |
170 | non-addictive | 4 |
171 | sub-antinociceptive | 1 |
172 | pre-g-csf | 1 |
173 | helminth-egg | 1 |
174 | ~10-mg | 1 |
175 | diverging | 51 |
176 | differing | 1,259 |
177 | propagating | 72 |
178 | propogating | 1 |
179 | deviating | 40 |
180 | contrasting | 408 |
181 | varying | 2,968 |
182 | non-fistulizing | 1 |
183 | device/drug | 2 |
184 | middle-high | 6 |
185 | medium-to-high | 9 |
186 | low-to-high | 11 |
187 | homoiothermical | 1 |
188 | low-spatial | 1 |
189 | andfinal | 1 |
190 | adimensional | 1 |
191 | 100-microm | 3 |
192 | bspharm | 2 |
193 | discussion.main | 1 |
194 | agreement.main | 1 |
195 | increasing-on-admission | 1 |
196 | lower-radiation | 1 |
197 | isocoagulation | 1 |
198 | hydration-dehydration | 1 |
199 | iron-saturation | 1 |
200 | neitralisation | 1 |
201 | two-actuation | 1 |
202 | medigap | 1 |
203 | respectively.similar | 1 |
204 | nonomolar | 1 |
205 | standard/higher | 1 |
206 | flexible-monomer | 2 |
207 | varicella/zoster | 1 |
208 | infant-series | 1 |
209 | microbiopsies | 3 |
210 | dibenzo-alpha-pyrones | 1 |
211 | non-simultaneous | 3 |
212 | sulfurous-arsenical-ferruginous | 1 |
213 | small-effect | 1 |
214 | single-digit | 16 |
215 | weight-equivalent | 1 |
216 | before-treatment | 3 |
217 | two-different | 1 |
218 | uranyl-cyt | 1 |
219 | np-v | 2 |
220 | superlow | 1 |
221 | medium-potency | 2 |
222 | plausability | 1 |
223 | very-low-activity | 2 |
224 | mid-khz | 1 |
225 | βz | 2 |
226 | 20× | 9 |
227 | 131° | 1 |